A detailed history of Segall Bryant & Hamill, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 157,144 shares of KRYS stock, worth $25.3 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
157,144
Previous 34,737 352.38%
Holding current value
$25.3 Million
Previous $6.38 Million 347.97%
% of portfolio
0.4%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$174.7 - $213.66 $21.4 Million - $26.2 Million
122,407 Added 352.38%
157,144 $28.6 Million
Q2 2024

Aug 14, 2024

BUY
$153.12 - $183.64 $5.32 Million - $6.38 Million
34,737 New
34,737 $6.38 Million

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.13B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.